Report Provides an Update on the 340B Drug Pricing Program

December 17, 2015

The American Journal of Managed Care (Dangi-Garimella, 12/17) summarized a study by the Berkeley Research Group (BRG), which was an update to a report released earlier in 2015 that examined Medicare Part B spending by 340B covered entities. “The study used data from Medicare fee-for-service (FFS) hospital outpatient claims, Medicare FFS physician office claims, hospital cost reports, and data from Office of Pharmacy Affairs. The new analysis found an increase in Medicare Part B hospital outpatient drug reimbursement in 2014 compared with 2013: it was 61% in 2014 and 58% in 2013.”